Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haude

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
Circulation. Cardiovascular Interventions|January 31, 2015
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trialStephan Windecker, Michael Haude, Franz-Josef Neumann, et al.
Journal of the American College of Cardiology|October 18, 2003
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein graftsVolker Schächinger, Christian W Hamm, Thomas Münzel, et al.
Lancet (London, England)|September 19, 2014
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.
European Heart Journal|October 12, 2017
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Davide Capodanno, Anna S Petronio, Bernard Prendergast, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 7, 2017
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Davide Capodanno, Anna S Petronio, Bernard Prendergast, et al.
International Journal of Cardiology|September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trialChao Gao, Kuniaki Takahashi, Scot Garg, et al.
Lancet (London, England)|November 4, 2016
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialPatrick W Serruys, Bernard Chevalier, Yohei Sotomi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 16, 2024
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human studyMasaru Seguchi, Alp Aytekin, Erion Xhepa, et al.
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
Circulation|September 20, 2006
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptorGregor Theilmeier, Christoph Schmidt, Jörg Herrmann, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
Circulation. Cardiovascular Interventions|January 31, 2015
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trialStephan Windecker, Michael Haude, Franz-Josef Neumann, et al.
Journal of the American College of Cardiology|October 18, 2003
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein graftsVolker Schächinger, Christian W Hamm, Thomas Münzel, et al.
Lancet (London, England)|September 19, 2014
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialPatrick W Serruys, Bernard Chevalier, Dariusz Dudek, et al.
European Heart Journal|October 12, 2017
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Davide Capodanno, Anna S Petronio, Bernard Prendergast, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 7, 2017
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Davide Capodanno, Anna S Petronio, Bernard Prendergast, et al.
International Journal of Cardiology|September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trialChao Gao, Kuniaki Takahashi, Scot Garg, et al.
Lancet (London, England)|November 4, 2016
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialPatrick W Serruys, Bernard Chevalier, Yohei Sotomi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 16, 2024
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human studyMasaru Seguchi, Alp Aytekin, Erion Xhepa, et al.
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
Circulation|September 20, 2006
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptorGregor Theilmeier, Christoph Schmidt, Jörg Herrmann, et al.
Pageof 21